Welcome to the 21^st World Nephrology Conference, scheduled to be held on March 24-25, 2025, in the vibrant city of Amsterdam, Netherlands. This conference, also known as World Nephrology 2025, promises to be a gathering of renowned experts, scholars, and practitioners in the fields of nephrology, urology, and therapeutics.

The theme of World Nephrology 2025 is "Recent advancements of research and treatment in the field of nephrology." This theme underscores our commitment to exploring the latest research findings, technologies, and treatment modalities in nephrology and urology, with a focus on translating these advancements into practical applications for improved patient care.

World Nephrology 2025 aims to provide a platform for the exchange of knowledge and ideas among professionals involved in nephrology, urology, and therapeutics. The conference will feature a wide range of sessions, including keynote lectures, plenary sessions, interactive workshops, and poster presentations, covering the latest developments and best practices in the field.

Target Audience:

• Nephrologists

• Renal Practionists

• Kidney coordinators

• Renal Transplantation surgeons

• Physicians

• Scientists

• Nephrology Associations and Societies

• Business Entrepreneurs

• Training Institutes

• Software developing companies

• Manufacturing Medical Devices Companies

• Data Management Companies

• Students

• Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
• Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
• Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

•  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
•  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
• Abstracts should adhere to the specified format and guidelines provided on the conference website.